List of Excipients in API naproxen sodium, pseudoephedrine hydrochloride
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing naproxen sodium, pseudoephedrine hydrochloride
Detailed excipient profiles for naproxen sodium, pseudoephedrine hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
naproxen sodium, pseudoephedrine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
naproxen sodium, pseudoephedrine hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Wal-Mart Stores Inc | naproxen sodium, pseudoephedrine hydrochloride | 49035-792 |
| CVS WOONSOCKET PRESCRIPTION CENTER INCORPORATED | naproxen sodium, pseudoephedrine hydrochloride | 51316-339 |
| >Company | >Ingredient | >NDC |
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC. | naproxen sodium, pseudoephedrine hydrochloride | 0280-6045 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
naproxen sodium, pseudoephedrine hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Bayer HealthCare LLC. | naproxen sodium, pseudoephedrine hydrochloride | 0280-6045 |
| >Company | >Ingredient | >NDC |
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Wal-Mart Stores Inc | naproxen sodium, pseudoephedrine hydrochloride | 49035-792 |
| CVS WOONSOCKET PRESCRIPTION CENTER INCORPORATED | naproxen sodium, pseudoephedrine hydrochloride | 51316-339 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
naproxen sodium, pseudoephedrine hydrochloride drug variants containing LACTOSE MONOHYDRATE
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
naproxen sodium, pseudoephedrine hydrochloride drug variants containing MAGNESIUM STEARATE
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
naproxen sodium, pseudoephedrine hydrochloride drug variants containing POLYETHYLENE GLYCOL
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
naproxen sodium, pseudoephedrine hydrochloride drug variants containing POLYSORBATE 80
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
naproxen sodium, pseudoephedrine hydrochloride drug variants containing POVIDONE
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
naproxen sodium, pseudoephedrine hydrochloride drug variants containing SILICON DIOXIDE
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
naproxen sodium, pseudoephedrine hydrochloride drug variants containing TALC
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
naproxen sodium, pseudoephedrine hydrochloride drug variants containing TITANIUM DIOXIDE
naproxen sodium, pseudoephedrine hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch